Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.04 (3.33%)
Bid:
0.75
Ask:
1.24
Spread: 0.49 (65.333%)
Market Cap: £6.99m
MTC Live PriceLast checked at - London Stock Exchange

Intraday Mothercare Share Chart

Announcement re Refinancing

17 Oct 2024 16:00

Announcement re Refinancing

Refinancing

Mothercare plc (“Mothercare” or the “Company”), the specialist global brand for parents and young children, is pleased to announce a refinancing with GB Europe Management Services Ltd (“Gordon Brothers”) of the Company’s existing debt facilities.

The Board of Mothercare believes that these new secured debt facilities of £8 million, taken together with the gross consideration of £16 million from Reliance Brands Holding UK Limited (“Reliance) announced earlier today, delivers a de-leveraged Mothercare that can once more move forward with confidence and invest appropriately in the Company’s future development.

Clive Whiley, Chairman of Mothercare, commented:

“Today’s agreements with Reliance and Gordon Brothers strengthen our operations in South Asia and support a material reduction in our bank facilities and leverage.

We have worked closely with Gordon Brothers for over five years now and value its ongoing support for Mothercare. The revised facility agreement and related arrangements reflect the strength of that ongoing relationship and trust alongside recognising the accretive nature of the joint-venture to our equity valuation. For Mothercare, the reduction in the required facility size, funded by the formation of the joint venture, and the resulting significantly reduced cash interest cost, greatly improves our flexibility for FY25 and beyond.

Taking today’s developments together with the inherent strength of the business’s brand, we believe Mothercare can approach 2025 and beyond with a renewed and growing sense of confidence at the opportunities ahead, notwithstanding our ongoing cautious shorter term outlook, given the continuing challenges facing our Middle East operations.”

New Financing Arrangements with Gordon Brothers

Mothercare has applied the proceeds received from Reliance towards a refinancing of the Company’s existing debt facilities with Gordon Brothers. Under the terms of these new financing arrangements, the previous £19.5m term loan (which attracted interest at a rate of 13% per annum, plus SONIA, plus PIK interest of 1% per annum) has been replaced with:

an £8m 2 year term loan facility, which attracts interest at a rate of 4.8% per annum, plus SONIA (with a floor of 5.2%), plus PIK interest of 1% per annum, rising to 2% per annum through the term of the loan; and the granting to Gordon Brothers of new warrants to subscribe up to 43.4m new ordinary shares of Mothercare at a subscription price of 8.5p per share (the “Warrants”). These Warrants, which are exercisable for 5 years from the date of issue, contain certain anti-dilution rights which will operate so as to secure for Gordon Brothers the right to subscribe for an aggregate equity interest representing approximately 7% of the Company’s issued share capital (following exercise in full of the Warrants).

Overall Financial Impact of the Joint Venture Arrangements and Refinancing

For the financial year ended 30 March 2024, the intellectual property assets that were transferred to JVCO 2024, which had no associated balance sheet carrying value, generated Mothercare retail sales under the previous franchise arrangements of approximately £24 million (approximately 9% of the total retail sales), and contributed approximately £0.9 million to adjusted EBITDA.

The result of the restructuring of its operations in South Asia and the associated sale of the 51% stake in JVCO 2024, Mothercare estimates will result in a taxable gain of £29 million and – after the use of certain preexisting tax losses – a cash tax cost of approximately £3 million. Taking into account this and other pre-completion adjustments, refinancing expenses, transactional costs and associated additional pension deficit payments, Mothercare expects to apply approximately £11.5 million of net cash proceeds to refinance the existing Gordon Brothers facilities as outlined above.

Following the completion of these transactions, we expect to announce the preliminary results for the year ended 30 March 2024 tomorrow.

Investor and analyst enquiries to:

Mothercare plc Email: investorrelations@mothercare.comClive Whiley, ChairmanAndrew Cook, Chief Financial Officer

Deutsche Numis | Deutsche Bank AG Tel: 020 7260 1000(NOMAD & Joint Corporate Broker) Luke BordewichHenry Slater

Cavendish Capital Markets Tel: 020 7220 0500(Joint Corporate Broker) Carl Holmes

Media enquiries to:

MHPTim Rowntree Email: mothercare@mhpgroup.comRachel Farrington Phone: 07801 894577

Date   Source Headline
25th Sep 20239:15 amGNWDirector/PDMR Shareholding
25th Sep 20237:00 amGNWAnnual Report and Accounts and Notice of AGM
22nd Sep 202312:33 pmGNWDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSFull Year Results 2023
13th Sep 20237:19 amGNWBlock listing Interim Review
4th Jul 20239:43 amGNWHolding(s) in Company
9th Jun 20237:00 amGNWDirectorate change
4th May 20237:00 amGNWPre-close Trading Update
27th Mar 20238:06 amGNWDirector/PDMR Shareholding
13th Mar 20238:00 amGNWBlock listing Interim Review
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
8th Feb 202310:45 amRNSDirector/PDMR Shareholding
3rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20239:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSFurther re: Appointment of Chief Executive Officer
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim results announcement
24th Nov 20227:00 amGNWAppointment of Chief Executive Officer
21st Nov 20224:36 pmRNSPrice Monitoring Extension
13th Oct 202212:38 pmGNWAGM Statement
16th Sep 20228:04 amGNWAnnual Report and Accounts and Notice of AGM
14th Sep 20221:31 pmGNWDirector/PDMR Shareholding
13th Sep 20224:40 pmRNSSecond Price Monitoring Extn
13th Sep 20224:35 pmRNSPrice Monitoring Extension
13th Sep 20224:12 pmGNWBlock listing Interim Review
13th Sep 20223:38 pmRNSFull Year Results 2022
16th May 20224:41 pmRNSSecond Price Monitoring Extn
16th May 20224:35 pmRNSPrice Monitoring Extension
4th May 20224:40 pmRNSSecond Price Monitoring Extn
4th May 20224:36 pmRNSPrice Monitoring Extension
11th Apr 20227:00 amGNWPre-close Trading Update
14th Mar 20229:12 amGNWBlock listing Interim Review
9th Mar 20227:00 amRNSStatement re Russia
24th Feb 20223:36 pmGNWHolding(s) in Company
24th Feb 202212:38 pmGNWHolding(s) in Company
4th Jan 20228:42 amGNWHolding(s) in Company
25th Nov 20217:00 amRNSInterim results announcement
27th Oct 202110:52 amGNWHolding(s) in Company
13th Sep 20218:15 amGNWBlock listing Interim Review
9th Sep 202111:49 amGNWAGM Statement and trading update
7th Sep 20217:10 amGNWHolding(s) in Company
10th Aug 202111:30 amGNWNotice of Annual General Meeting and Annual Report and Accounts
3rd Aug 20214:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20217:00 amRNSFinal Results
5th Jul 20217:15 amGNWHolding(s) in Company
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.